DudeDiligence.

Korro Bio, Inc

KRRONASDAQ · Pharmaceutical Preparations
Write an idea

Price

From the filings

Figures

Revenue
$1.3Mlast 12 months
Net income
−$106.1Mlast 12 months
Operating cash flow
−$67.9Mlast 12 months
Cash and equivalents
$40.2Mat the last balance sheet
Shares outstanding
13.7M shareson issue
Every year and quarter →